1660 / 1840
HDR BOOST with EBRT
•
Optimal means of dose escalation for
intermediate/high risk patients
•
Dose escalation results in better PSA RFS
•
Acute toxicity equivalent or less than
external beam
•
Late toxicity equivalent to external beam